Matches in Wikidata for { <http://www.wikidata.org/entity/Q91104415> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q91104415 description "article scientifique publié en 2019" @default.
- Q91104415 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91104415 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91104415 description "scientific article published on 01 November 2019" @default.
- Q91104415 description "wetenschappelijk artikel" @default.
- Q91104415 description "наукова стаття, опублікована 1 листопада 2019" @default.
- Q91104415 name "Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety" @default.
- Q91104415 name "Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety" @default.
- Q91104415 type Item @default.
- Q91104415 label "Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety" @default.
- Q91104415 label "Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety" @default.
- Q91104415 prefLabel "Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety" @default.
- Q91104415 prefLabel "Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety" @default.
- Q91104415 P1433 Q91104415-94D90EA0-1685-47D0-B6E9-4614A3F7817D @default.
- Q91104415 P1476 Q91104415-F11B71AC-6C53-4544-A645-3E552B3A3C2E @default.
- Q91104415 P2093 Q91104415-0EE17B96-3079-42EB-99FD-BC44743E1EC5 @default.
- Q91104415 P2093 Q91104415-168BFDCB-070D-41C9-9CD3-7E78073CB96C @default.
- Q91104415 P2093 Q91104415-2CBE333F-4B3E-47A0-8539-BE9AD0126939 @default.
- Q91104415 P2093 Q91104415-3CAEA981-D104-4D96-8C0B-E7FEF05CC45F @default.
- Q91104415 P2093 Q91104415-558D1EFA-7113-4941-A044-4729D77BE332 @default.
- Q91104415 P2093 Q91104415-67ED5251-D8CE-47C0-A718-76F902CA5E9E @default.
- Q91104415 P2093 Q91104415-7270A7C4-4960-47E6-9EB2-E61642C05332 @default.
- Q91104415 P2093 Q91104415-9AEC9C66-93FF-4B73-8A87-71FA6132EF13 @default.
- Q91104415 P2093 Q91104415-B1A7DA45-E7BE-429D-A0D5-5C886C73A861 @default.
- Q91104415 P2093 Q91104415-C221A099-D10C-4969-A324-BA59080934BB @default.
- Q91104415 P2093 Q91104415-CCFF9755-DBDF-4FFC-AD7C-73600BEF9A79 @default.
- Q91104415 P2093 Q91104415-E4EE6703-AED3-4856-88F4-93E1B04C1A97 @default.
- Q91104415 P304 Q91104415-C077F9ED-7BB6-4C79-9574-60123849E504 @default.
- Q91104415 P31 Q91104415-A4DA5C56-01EF-41F0-9750-23877BF28ABF @default.
- Q91104415 P356 Q91104415-63E35301-43AF-458A-8BC0-0FF1D662212A @default.
- Q91104415 P433 Q91104415-9CF4B3CF-017B-449E-9302-ED624E4458DA @default.
- Q91104415 P478 Q91104415-F5BE3A55-DE22-4414-B54B-787EA6DA3824 @default.
- Q91104415 P50 Q91104415-022C64E5-43DD-45CC-B564-AF7F2F693B8B @default.
- Q91104415 P50 Q91104415-982401BC-3842-4545-9246-772314EA872E @default.
- Q91104415 P50 Q91104415-BF829E94-B4F5-4B74-BC12-3D26D2110423 @default.
- Q91104415 P577 Q91104415-031C658C-BF9E-49C8-A897-F8A918775CDE @default.
- Q91104415 P698 Q91104415-EA3A6B31-5482-4377-AFB2-A0D7C54C75DC @default.
- Q91104415 P921 Q91104415-1F3FE89A-1A81-4F47-B1DD-E5DC3310673B @default.
- Q91104415 P356 IJGC-2019-000623 @default.
- Q91104415 P698 31685558 @default.
- Q91104415 P1433 Q15749181 @default.
- Q91104415 P1476 "Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety" @default.
- Q91104415 P2093 "Alexandra Leary" @default.
- Q91104415 P2093 "Amit M Oza" @default.
- Q91104415 P2093 "Ana Oaknin" @default.
- Q91104415 P2093 "Domenica Lorusso" @default.
- Q91104415 P2093 "Iain A McNeish" @default.
- Q91104415 P2093 "Jonathan A Ledermann" @default.
- Q91104415 P2093 "Lara Maloney" @default.
- Q91104415 P2093 "Rebecca S Kristeleit" @default.
- Q91104415 P2093 "Sandra Goble" @default.
- Q91104415 P2093 "Susan M Domchek" @default.
- Q91104415 P2093 "Terri Cameron" @default.
- Q91104415 P2093 "Yvette Drew" @default.
- Q91104415 P304 "1396-1404" @default.
- Q91104415 P31 Q13442814 @default.
- Q91104415 P356 "10.1136/IJGC-2019-000623" @default.
- Q91104415 P433 "9" @default.
- Q91104415 P478 "29" @default.
- Q91104415 P50 Q104281949 @default.
- Q91104415 P50 Q37995869 @default.
- Q91104415 P50 Q41839999 @default.
- Q91104415 P577 "2019-11-01T00:00:00Z" @default.
- Q91104415 P698 "31685558" @default.
- Q91104415 P921 Q172341 @default.